Carregant...
The Use of Positron Emission Tomography in Soft Tissue Sarcoma Patients under Therapy with Trabectedin
BACKGROUND: We used 2-deoxy-2-[(18)F] fluoro-D-glucose (FDG) positron emission tomography (PET) to evaluate the FDG uptake in patients with advanced and/or metastatic soft tissue sarcoma (STS) undergoing therapy with Ecteinascidin-743 (ET-743, Trabectedin, Yondelis™). PATIENTS AND METHODS: The pilot...
Guardat en:
| Autors principals: | , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Molecular Diversity Preservation International
2009
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2763103/ https://ncbi.nlm.nih.gov/pubmed/19841717 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/md7030331 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|